Premium
Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model
Author(s) -
Chen YiHao,
Liang ChangMin,
Chen ChingLong,
Chen JiannTorng,
Chang YunHsiang,
Lu DaWen,
Chien KeHung,
Tai MingCheng
Publication year - 2013
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.12160
Subject(s) - myofibroblast , transdifferentiation , mortise and tenon , silibinin , trabeculectomy , rabbit (cipher) , fibrosis , medicine , ophthalmology , cancer research , microbiology and biotechnology , pathology , glaucoma , biology , stem cell , structural engineering , engineering , statistics , mathematics
Abstract. Purpose: To investigate the effect of silibinin in myofibroblast transdifferentiation and in animal trabeculectomy models. Methods: The effect of silibinin on the expression of α‐smooth muscle actin (α‐SMA) and vimentin in response to transforming growth factor‐β1 (TGF‐β1) was determined in human tenon fibroblasts (HTFs). Cell migration and collagen contraction arrays were used to demonstrate the functionality of silibinin‐modulated HTFs. ELISA analysis was used to determine the effect of silibinin on the release of type 1 collagen and connective tissue growth factor (CTGF). The effect of silibinin on the activation of the TGF‐β receptor–related pathway was evaluated by Western blotting. A rabbit model of trabeculectomy was established to assess the effect of silibinin in vivo. Results: TGF‐β1 elevated the expression of α‐SMA and vimentin in HTFs; this elevation was inhibited by silibinin. TGF‐β1 increased cell migration and collagen contraction of HTFs, which were also suppressed by silibinin. The production of both CTGF and type 1 collagen in TGF‐β1‐treated HTFs was inhibited by silibinin. The effects of silibinin on TGF‐β1‐stimulated HTFs were mediated via the down‐regulation of TGF‐β receptor–related SMAD signalling pathways. In the rabbit model of trabeculectomy, silibinin increased the period of decreasing intraocular pressure after trabeculectomy and reduced the production of collagen and α‐SMA at the site of blebs in vivo. Conclusion: Silibinin inhibited the TGF‐β receptor–related signalling pathway in TGF‐β‐treated HTFs and several of the downstream events associated with myofibroblast transdifferentiation. Silibinin also improved the outcome of trabeculectomies by reducing the fibrotic response in the bleb tissue in vivo.